Literature DB >> 21725054

MicroRNA function in myeloid biology.

Ryan M O'Connell1, Jimmy L Zhao, Dinesh S Rao.   

Abstract

The past 5 years have seen an explosion of knowledge about miRNAs and their roles in hematopoiesis, cancer, and other diseases. In myeloid development, there is a growing appreciation for both the importance of particular miRNAs and the unique features of myelopoiesis that are being uncovered by experimental manipulation of miRNAs. Here, we review in detail the roles played by 4 miRNAs, miR-125, miR-146, miR-155, and miR-223 in myeloid development and activation, and correlate these roles with their dysregulation in disease. All 4 miRNAs demonstrate effects on myelopoiesis, and their loss of function or overexpression leads to pathologic phenotypes in the myeloid lineage. We review their functions at distinct points in development, their targets, and the regulatory networks that they are embedded into in the myeloid lineage.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21725054      PMCID: PMC3175776          DOI: 10.1182/blood-2011-03-291971

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  100 in total

Review 1.  Physiological and pathological roles for microRNAs in the immune system.

Authors:  Ryan M O'Connell; Dinesh S Rao; Aadel A Chaudhuri; David Baltimore
Journal:  Nat Rev Immunol       Date:  2010-02       Impact factor: 53.106

2.  miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts.

Authors:  Anna M Eiring; Jason G Harb; Paolo Neviani; Christopher Garton; Joshua J Oaks; Riccardo Spizzo; Shujun Liu; Sebastian Schwind; Ramasamy Santhanam; Christopher J Hickey; Heiko Becker; Jason C Chandler; Raul Andino; Jorge Cortes; Peter Hokland; Claudia S Huettner; Ravi Bhatia; Denis C Roy; Stephen A Liebhaber; Michael A Caligiuri; Guido Marcucci; Ramiro Garzon; Carlo M Croce; George A Calin; Danilo Perrotti
Journal:  Cell       Date:  2010-03-05       Impact factor: 41.582

3.  Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia.

Authors:  John A Pulikkan; Viola Dengler; Philomina S Peramangalam; Abdul A Peer Zada; Carsten Müller-Tidow; Stefan K Bohlander; Daniel G Tenen; Gerhard Behre
Journal:  Blood       Date:  2009-12-22       Impact factor: 22.113

4.  miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia.

Authors:  Jan-Henning Klusmann; Zhe Li; Katarina Böhmer; Aliaksandra Maroz; Mia Lee Koch; Stephan Emmrich; Frank J Godinho; Stuart H Orkin; Dirk Reinhardt
Journal:  Genes Dev       Date:  2010-03-01       Impact factor: 11.361

5.  Complexity of miR-223 regulation by CEBPA in human AML.

Authors:  Marianne Eyholzer; Sabine Schmid; Julian A Schardt; Simon Haefliger; Beatrice U Mueller; Thomas Pabst
Journal:  Leuk Res       Date:  2009-12-16       Impact factor: 3.156

6.  microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia.

Authors:  Yoon-Chi Han; Christopher Y Park; Govind Bhagat; Jinping Zhang; Yulei Wang; Jian-Bing Fan; Mofang Liu; Yongrui Zou; Irving L Weissman; Hua Gu
Journal:  J Exp Med       Date:  2010-03-08       Impact factor: 14.307

7.  Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21.

Authors:  Frederick J Sheedy; Eva Palsson-McDermott; Elizabeth J Hennessy; Cara Martin; John J O'Leary; Qingguo Ruan; Derek S Johnson; Youhai Chen; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2009-11-29       Impact factor: 25.606

8.  Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.

Authors:  Daniel T Starczynowski; Florian Kuchenbauer; Bob Argiropoulos; Sandy Sung; Ryan Morin; Andrew Muranyi; Martin Hirst; Donna Hogge; Marco Marra; Richard A Wells; Rena Buckstein; Wan Lam; R Keith Humphries; Aly Karsan
Journal:  Nat Med       Date:  2009-11-08       Impact factor: 53.440

9.  MicroRNA 29b functions in acute myeloid leukemia.

Authors:  Ramiro Garzon; Catherine E A Heaphy; Violaine Havelange; Muller Fabbri; Stefano Volinia; Twee Tsao; Nicola Zanesi; Steven M Kornblau; Guido Marcucci; George A Calin; Michael Andreeff; Carlo M Croce
Journal:  Blood       Date:  2009-10-22       Impact factor: 22.113

10.  Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53.

Authors:  N Gefen; V Binder; M Zaliova; Y Linka; M Morrow; A Novosel; L Edry; L Hertzberg; N Shomron; O Williams; J Trka; A Borkhardt; S Izraeli
Journal:  Leukemia       Date:  2009-11-05       Impact factor: 11.528

View more
  69 in total

Review 1.  MicroRNA, nutrition, and cancer prevention.

Authors:  Sharon A Ross; Cindy D Davis
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

2.  Decreased circulating microRNA-223 level predicts high on-treatment platelet reactivity in patients with troponin-negative non-ST elevation acute coronary syndrome.

Authors:  Ying-Ying Zhang; Xin Zhou; Wen-Jie Ji; Rui Shi; Rui-Yi Lu; Jin-Long Li; Guo-Hong Yang; Tao Luo; Jian-Qi Zhang; Ji-Hong Zhao; Tie-Min Jiang; Yu-Ming Li
Journal:  J Thromb Thrombolysis       Date:  2014-07       Impact factor: 2.300

3.  Distinct microRNA expression profile and targeted biological pathways in functional myeloid-derived suppressor cells induced by Δ9-tetrahydrocannabinol in vivo: regulation of CCAAT/enhancer-binding protein α by microRNA-690.

Authors:  Venkatesh L Hegde; Sunil Tomar; Austin Jackson; Roshni Rao; Xiaoming Yang; Udai P Singh; Narendra P Singh; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Biol Chem       Date:  2013-11-07       Impact factor: 5.157

4.  Regulating Tumor Myeloid-Derived Suppressor Cells by MicroRNAs.

Authors:  Siqi Chen; Yi Zhang; Timothy M Kuzel; Bin Zhang
Journal:  Cancer Cell Microenviron       Date:  2015

Review 5.  MicroRNAs as biomarkers of cervical cancer development: a literature review on miR-125b and miR-34a.

Authors:  Joana Ribeiro; Hugo Sousa
Journal:  Mol Biol Rep       Date:  2014-01-09       Impact factor: 2.316

6.  MicroRNA 21 (miR-21) and miR-181b couple with NFI-A to generate myeloid-derived suppressor cells and promote immunosuppression in late sepsis.

Authors:  Clara McClure; Laura Brudecki; Donald A Ferguson; Zhi Q Yao; Jonathan P Moorman; Charles E McCall; Mohamed El Gazzar
Journal:  Infect Immun       Date:  2014-06-30       Impact factor: 3.441

7.  Alleviating the progression of acute myeloid leukemia (AML) by sulforaphane through controlling miR-155 levels.

Authors:  Mohsen Koolivand; Maryam Ansari; Fatemeh Piroozian; Soheila Moein; Kianoosh MalekZadeh
Journal:  Mol Biol Rep       Date:  2018-10-22       Impact factor: 2.316

8.  MicroRNA-125b-1 accelerates a C-terminal mutant of C/EBPα (C/EBPα-C(m))-induced myeloid leukemia.

Authors:  Yutaka Enomoto; Jiro Kitaura; Masaya Shimanuki; Naoko Kato; Koutarou Nishimura; Mariko Takahashi; Hideki Nakakuma; Toshio Kitamura; Takashi Sonoki
Journal:  Int J Hematol       Date:  2012-07-28       Impact factor: 2.490

9.  miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis.

Authors:  Ruggiero Norfo; Roberta Zini; Valentina Pennucci; Elisa Bianchi; Simona Salati; Paola Guglielmelli; Costanza Bogani; Tiziana Fanelli; Carmela Mannarelli; Vittorio Rosti; Daniela Pietra; Silvia Salmoiraghi; Andrea Bisognin; Samantha Ruberti; Sebastiano Rontauroli; Giorgia Sacchi; Zelia Prudente; Giovanni Barosi; Mario Cazzola; Alessandro Rambaldi; Stefania Bortoluzzi; Sergio Ferrari; Enrico Tagliafico; Alessandro M Vannucchi; Rossella Manfredini
Journal:  Blood       Date:  2014-08-05       Impact factor: 22.113

10.  Patterns of gene expression among murine models of hemorrhagic shock/trauma and sepsis.

Authors:  Juan C Mira; Benjamin E Szpila; Dina C Nacionales; Maria-Cecilia Lopez; Lori F Gentile; Brittany J Mathias; Erin L Vanzant; Ricardo Ungaro; David Holden; Martin D Rosenthal; Jaimar Rincon; Patrick T Verdugo; Shawn D Larson; Frederick A Moore; Scott C Brakenridge; Alicia M Mohr; Henry V Baker; Lyle L Moldawer; Philip A Efron
Journal:  Physiol Genomics       Date:  2015-11-17       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.